Advances in the development of nanomedicines for treating chronic kidney disease
Chronic kidney disease（CKD） is a group of chronic diseases with high morbidity and mortality. There is no effective curative therapeutic for CKD. Traditional therapeutics of CKD have major disadvantages， such as poor renal-targeting property and serious side effects. The latest evidence shows that n...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Nephrology
2025-06-01
|
| Series: | Linchuang shenzangbing zazhi |
| Subjects: | |
| Online Access: | http://www.lcszb.com/thesisDetails#10.3969/j.issn.1671-2390.2025.06.010 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849421412209524736 |
|---|---|
| author | He Yu-han Li Yu-pei Su Bai-hai |
| author_facet | He Yu-han Li Yu-pei Su Bai-hai |
| author_sort | He Yu-han |
| collection | DOAJ |
| description | Chronic kidney disease（CKD） is a group of chronic diseases with high morbidity and mortality. There is no effective curative therapeutic for CKD. Traditional therapeutics of CKD have major disadvantages， such as poor renal-targeting property and serious side effects. The latest evidence shows that nanomedicines have great potential in the treatment of CKD. Nanomedicines provide good physicochemical properties and biological characteristics， and can precisely deliver the loaded drug to the kidneys to improve the therapeutic effect of CKD. In this review， we first reviewed the pathological mechanisms of CKD progression， and then discussed recent advances in the use of nanomedicines for CKD treatment. |
| format | Article |
| id | doaj-art-e90de38f7dae475cb67ddc73d2f898b1 |
| institution | Kabale University |
| issn | 1671-2390 |
| language | zho |
| publishDate | 2025-06-01 |
| publisher | Editorial Department of Journal of Clinical Nephrology |
| record_format | Article |
| series | Linchuang shenzangbing zazhi |
| spelling | doaj-art-e90de38f7dae475cb67ddc73d2f898b12025-08-20T03:31:27ZzhoEditorial Department of Journal of Clinical NephrologyLinchuang shenzangbing zazhi1671-23902025-06-0125516520112447772Advances in the development of nanomedicines for treating chronic kidney diseaseHe Yu-hanLi Yu-peiSu Bai-haiChronic kidney disease（CKD） is a group of chronic diseases with high morbidity and mortality. There is no effective curative therapeutic for CKD. Traditional therapeutics of CKD have major disadvantages， such as poor renal-targeting property and serious side effects. The latest evidence shows that nanomedicines have great potential in the treatment of CKD. Nanomedicines provide good physicochemical properties and biological characteristics， and can precisely deliver the loaded drug to the kidneys to improve the therapeutic effect of CKD. In this review， we first reviewed the pathological mechanisms of CKD progression， and then discussed recent advances in the use of nanomedicines for CKD treatment.http://www.lcszb.com/thesisDetails#10.3969/j.issn.1671-2390.2025.06.010Chronic kidney diseaseNanomedicinesRenal deliveryTreatment |
| spellingShingle | He Yu-han Li Yu-pei Su Bai-hai Advances in the development of nanomedicines for treating chronic kidney disease Linchuang shenzangbing zazhi Chronic kidney disease Nanomedicines Renal delivery Treatment |
| title | Advances in the development of nanomedicines for treating chronic kidney disease |
| title_full | Advances in the development of nanomedicines for treating chronic kidney disease |
| title_fullStr | Advances in the development of nanomedicines for treating chronic kidney disease |
| title_full_unstemmed | Advances in the development of nanomedicines for treating chronic kidney disease |
| title_short | Advances in the development of nanomedicines for treating chronic kidney disease |
| title_sort | advances in the development of nanomedicines for treating chronic kidney disease |
| topic | Chronic kidney disease Nanomedicines Renal delivery Treatment |
| url | http://www.lcszb.com/thesisDetails#10.3969/j.issn.1671-2390.2025.06.010 |
| work_keys_str_mv | AT heyuhan advancesinthedevelopmentofnanomedicinesfortreatingchronickidneydisease AT liyupei advancesinthedevelopmentofnanomedicinesfortreatingchronickidneydisease AT subaihai advancesinthedevelopmentofnanomedicinesfortreatingchronickidneydisease |